92 related articles for article (PubMed ID: 9023303)
1. Disposition of amodiaquine and related antimalarial agents in human neutrophils: implications for drug design.
Naisbitt DJ; Ruscoe JE; Williams D; O'Neill PM; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1997 Feb; 280(2):884-93. PubMed ID: 9023303
[TBL] [Abstract][Full Text] [Related]
2. Metabolism-dependent neutrophil cytotoxicity of amodiaquine: A comparison with pyronaridine and related antimalarial drugs.
Naisbitt DJ; Williams DP; O'Neill PM; Maggs JL; Willock DJ; Pirmohamed M; Park BK
Chem Res Toxicol; 1998 Dec; 11(12):1586-95. PubMed ID: 9860505
[TBL] [Abstract][Full Text] [Related]
3. Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials.
O'Neill PM; Mukhtar A; Stocks PA; Randle LE; Hindley S; Ward SA; Storr RC; Bickley JF; O'Neil IA; Maggs JL; Hughes RH; Winstanley PA; Bray PG; Park BK
J Med Chem; 2003 Nov; 46(23):4933-45. PubMed ID: 14584944
[TBL] [Abstract][Full Text] [Related]
4. Effect of disposition of mannich antimalarial agents on their pharmacology and toxicology.
Ruscoe JE; Tingle MD; O'Neill PM; Ward SA; Park BK
Antimicrob Agents Chemother; 1998 Sep; 42(9):2410-6. PubMed ID: 9736572
[TBL] [Abstract][Full Text] [Related]
5. Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine.
Jewell H; Maggs JL; Harrison AC; O'Neill PM; Ruscoe JE; Park BK
Xenobiotica; 1995 Feb; 25(2):199-217. PubMed ID: 7618347
[TBL] [Abstract][Full Text] [Related]
6. The bioactivation of amodiaquine by human polymorphonuclear leucocytes in vitro: chemical mechanisms and the effects of fluorine substitution.
Tingle MD; Jewell H; Maggs JL; O'Neill PM; Park BK
Biochem Pharmacol; 1995 Sep; 50(7):1113-9. PubMed ID: 7575670
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
Mengesha T; Makonnen E
East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
[TBL] [Abstract][Full Text] [Related]
8. Amodiaquine-induced oxidative stress in a hepatocyte inflammation model.
Tafazoli S; O'Brien PJ
Toxicology; 2009 Feb; 256(1-2):101-9. PubMed ID: 19059302
[TBL] [Abstract][Full Text] [Related]
9. Replacement of the 4'-hydroxy group of amodiaquine and amopyroquine by aromatic and aliphatic substituents: synthesis and antimalarial activity.
Păunescu E; Susplugas S; Boll E; Varga R; Mouray E; Grosu I; Grellier P; Melnyk P
ChemMedChem; 2009 Apr; 4(4):549-61. PubMed ID: 19212949
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquine.
O'Neill PM; Shone AE; Stanford D; Nixon G; Asadollahy E; Park BK; Maggs JL; Roberts P; Stocks PA; Biagini G; Bray PG; Davies J; Berry N; Hall C; Rimmer K; Winstanley PA; Hindley S; Bambal RB; Davis CB; Bates M; Gresham SL; Brigandi RA; Gomez-de-Las-Heras FM; Gargallo DV; Parapini S; Vivas L; Lander H; Taramelli D; Ward SA
J Med Chem; 2009 Apr; 52(7):1828-44. PubMed ID: 19284751
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimalarial activity of new isotebuquine analogues.
Miroshnikova OV; Hudson TH; Gerena L; Kyle DE; Lin AJ
J Med Chem; 2007 Feb; 50(4):889-96. PubMed ID: 17266295
[TBL] [Abstract][Full Text] [Related]
12. Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component.
Hawley SR; Bray PG; O'Neill PM; Naisbitt DJ; Park BK; Ward SA
Antimicrob Agents Chemother; 1996 Oct; 40(10):2345-9. PubMed ID: 8891142
[TBL] [Abstract][Full Text] [Related]
13. 4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake.
Bray PG; Hawley SR; Ward SA
Mol Pharmacol; 1996 Dec; 50(6):1551-8. PubMed ID: 8967977
[TBL] [Abstract][Full Text] [Related]
14. Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro.
Labro MT; Babin-Chevaye C
Antimicrob Agents Chemother; 1988 Aug; 32(8):1124-30. PubMed ID: 3263835
[TBL] [Abstract][Full Text] [Related]
15. The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine.
O'Neill PM; Harrison AC; Storr RC; Hawley SR; Ward SA; Park BK
J Med Chem; 1994 Apr; 37(9):1362-70. PubMed ID: 8176713
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antimalarial activity, and molecular modeling of tebuquine analogues.
O'Neill PM; Willock DJ; Hawley SR; Bray PG; Storr RC; Ward SA; Park BK
J Med Chem; 1997 Feb; 40(4):437-48. PubMed ID: 9046333
[TBL] [Abstract][Full Text] [Related]
17. Electrochemical generation of electrophilic drug metabolites: characterization of amodiaquine quinoneimine and cysteinyl conjugates by MS, IR, and NMR.
Jurva U; Holmén A; Grönberg G; Masimirembwa C; Weidolf L
Chem Res Toxicol; 2008 Apr; 21(4):928-35. PubMed ID: 18361508
[TBL] [Abstract][Full Text] [Related]
18. Novel amodiaquine congeners as potent antimalarial agents.
Casagrande M; Basilico N; Parapini S; Romeo S; Taramelli D; Sparatore A
Bioorg Med Chem; 2008 Jul; 16(14):6813-23. PubMed ID: 18562202
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal trapping of amodiaquine: impact on transport across intestinal epithelia models.
Hayeshi R; Masimirembwa C; Mukanganyama S; Ungell AL
Biopharm Drug Dispos; 2008 Sep; 29(6):324-34. PubMed ID: 18570280
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial drug toxicity: a review.
AlKadi HO
Chemotherapy; 2007; 53(6):385-91. PubMed ID: 17934257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
